
doi: 10.1002/pbc.20793
pmid: 16572402
AbstractBackgroundTrilateral retinoblastoma (TRB) is a syndrome consisting of unilateral or bilateral hereditary retinoblastoma (Rb) associated with an intracranial neuroblastic tumor. Although its incidence is low, the prognosis is very poor. This article reports four cases of TRB and discusses the role of neuroimaging screening for early detection.ProcedureFrom January 1986 to December 2003, 470 children with Rb were admitted to the Pediatrics and Ophthalmology Departments, A C Camargo Hospital, São Paulo, Brazil.ResultsThere were four patients with pineoblastoma, two of whom had a positive familial history. The age at diagnosis of Rb was 4, 6, 10, and 24 months while the age of diagnosis of TRB was 10, 25, 57, and 72 months. One patient presented TRB at initial diagnosis of Rb. Three patients had bilateral disease and all of them had one eye enucleated, followed by chemotherapy and/or external beam radiation therapy (EBRT). One child with unilateral disease was only submitted to enucleation. In spite of intensive treatment, all patients died with progressive disease within 7, 8, 12, and 12 months after diagnosis of TRB.ConclusionsEarly diagnosis as well as new therapeutic approaches are needed to achieve better results. Pediatr Blood Cancer 2007;48:306–310. © 2006 Wiley‐Liss, Inc.
Male, Eye Neoplasms, Neoplasms, Second Primary, Combined Modality Therapy, Eye Enucleation, Neoplasms, Multiple Primary, Fatal Outcome, Methotrexate, Neoplastic Syndromes, Hereditary, Child, Preschool, Antineoplastic Combined Chemotherapy Protocols, Disease Progression, Humans, Female, Ifosfamide, Cisplatin, Cranial Irradiation, Idarubicin, Cyclophosphamide, Etoposide
Male, Eye Neoplasms, Neoplasms, Second Primary, Combined Modality Therapy, Eye Enucleation, Neoplasms, Multiple Primary, Fatal Outcome, Methotrexate, Neoplastic Syndromes, Hereditary, Child, Preschool, Antineoplastic Combined Chemotherapy Protocols, Disease Progression, Humans, Female, Ifosfamide, Cisplatin, Cranial Irradiation, Idarubicin, Cyclophosphamide, Etoposide
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 29 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
